This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Novartis Ag. Active years: 2024-2025.
Company Filing History:
Years Active: 2024-2025
Title: The Innovative Contributions of Cyrille Kounde
Introduction
Cyrille Kounde is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address viral infections. With a total of 2 patents to his name, Kounde's work is recognized for its potential impact on medical treatments.
Latest Patents
Cyrille Kounde's latest patents include the "N-substituted tetrahydrothienopyridine derivatives and uses thereof." This compound, represented by Formula (I), has been shown to be useful for treating diseases caused by viral infections. The specific configurations of R, A, L, m, n, p, and q are defined within the patent documentation, highlighting the innovative nature of his work.
Career Highlights
Kounde is currently employed at Novartis AG, a leading global healthcare company. His role involves research and development, where he focuses on creating new therapeutic solutions. His expertise in medicinal chemistry has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Cyrille Kounde collaborates with several talented professionals, including Wei Lin, Sandra Sim, and Oliver Simon. These collaborations enhance the research environment and foster innovation within his projects.
Conclusion
Cyrille Kounde's contributions to the field of pharmaceuticals through his innovative patents and collaborative efforts at Novartis AG demonstrate his commitment to advancing medical science. His work holds promise for improving treatments for viral infections, showcasing the importance of innovation in healthcare.